Status:
COMPLETED
Continuous Interscalene Block Results in Superior Recovery Throughout the First Postoperative Week
Lead Sponsor:
St. Luke's-Roosevelt Hospital Center
Collaborating Sponsors:
Baxter Healthcare Corporation
Conditions:
Postoperative Pain
Adverse Effects
Eligibility:
All Genders
18-75 years
Phase:
EARLY_PHASE1
Brief Summary
The investigators undertook this prospective, randomized trial to compare the recovery profile throughout the first postoperative week in patients receiving continuous (CISB) interscalene brachial ple...
Detailed Description
Background The advantages of single injection (SISB) and continuous interscalene brachial plexus block (CISB) over general anesthesia (GA) only have been previously reported. However, few studies exte...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists (ASA) physical status I-III patients
- ≥ 18 years of age BMI ≤ 35 kg/m2 Scheduled for elective arthroscopic shoulder surgery
Exclusion
- Patients who were undertaken open shoulder procedures Patients with difficulty understanding the instructions for using the anesthetic infusion pump and/or pain scales Patients with contraindications to regional anesthesia (e.g., allergy to a local anesthetic (LA), local infection, coagulopathy) Patients with significant neurologic disorders of the upper extremity, psychiatric or cognitive disorders, history of substance abuse or chronic opioid use
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT01881776
Start Date
August 1 2011
End Date
June 1 2012
Last Update
June 4 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St Luke's Roosevelt Hospital Center
New York, New York, United States, 10025